S&P 500
(-0.34%) 5 018.39 points
Dow Jones
(0.23%) 37 903 points
Nasdaq
(-0.33%) 15 605 points
Oil
(0.51%) $79.40
Gas
(1.14%) $1.954
Gold
(0.83%) $2 330.20
Silver
(0.55%) $26.90
Platinum
(1.33%) $967.60
USD/EUR
(0.02%) $0.933
USD/NOK
(-0.07%) $11.02
USD/GBP
(-0.10%) $0.798
USD/RUB
(0.27%) $93.51

Sanntidsoppdatering for Microbix Biosystems Inc [MBX.TO]

Børs: TSX Industri: Biotechnology
Sist oppdatert1 mai 2024 @ 16:42

-1.45% $ 0.340

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 16:42):

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally...

Stats
Dagens volum 1 500.00
Gjennomsnittsvolum 76 504.00
Markedsverdi 46.43M
EPS $0 ( 2024-02-14 )
Neste inntjeningsdato ( $0 ) 2024-05-08
Last Dividend $0.275 ( 1999-09-02 )
Next Dividend $0 ( N/A )
P/E 11.33
ATR14 $0 (0.00%)

Microbix Biosystems Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Microbix Biosystems Inc Økonomi

Annual 2023
Omsetning: $16.51M
Bruttogevinst: $7.48M (45.30 %)
EPS: $-0.000300
FY 2023
Omsetning: $16.51M
Bruttogevinst: $7.48M (45.30 %)
EPS: $-0.000300
FY 2022
Omsetning: $19.08M
Bruttogevinst: $11.12M (58.32 %)
EPS: $0.0132
FY 2021
Omsetning: $18.59M
Bruttogevinst: $11.04M (59.40 %)
EPS: $0.0280

Financial Reports:

No articles found.

Microbix Biosystems Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Microbix Biosystems Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.10 - No dividend growth expected in the near future
Information
First Dividend $0.275 1999-09-02
Last Dividend $0.275 1999-09-02
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.275 --
Avg. Dividend % Per Year 0.00% --
Score 2.29 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 3.10
Div. Directional Score 7.60 --
Next Divdend (Est)
(2024-05-02)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
2.29
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0 0.00%
2004 $0 0.00%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for TSX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
ZRE.TO Dividend Knight 2023-08-29 Monthly 15 2.60%
TLF.TO Dividend King 2023-08-30 Monthly 13 3.15%
L-PB.TO Dividend King 2023-09-14 Quarterly 10 3.24%
CMAR.TO Dividend Knight 2023-09-22 Monthly 5 2.05%
XLB.TO Dividend Knight 2023-08-25 Monthly 19 1.89%
PZA.TO Dividend Royal 2023-09-28 Monthly 20 4.10%
FM.TO Dividend Junior 2023-08-25 Semi-Annually 20 0.32%
ABST.TO Dividend Knight 2023-05-10 Quarterly 12 1.37%
VBAL.TO Dividend Junior 2023-07-05 Quarterly 7 1.11%
MR-UN.TO Dividend King 2023-09-28 Monthly 12 4.52%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1571.5006.8710.00[0 - 0.5]
returnOnAssetsTTM0.09571.2006.818.17[0 - 0.3]
returnOnEquityTTM0.1441.5009.5210.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM8.530.80010.008.00[1 - 3]
quickRatioTTM5.990.80010.008.00[0.8 - 2.5]
cashRatioTTM4.601.50010.0010.00[0.2 - 2]
debtRatioTTM0.164-1.5007.27-10.00[0 - 0.6]
interestCoverageTTM5.121.0009.219.21[3 - 30]
operatingCashFlowPerShareTTM0.007022.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.0002742.0010.0010.00[0 - 20]
debtEquityRatioTTM0.221-1.5009.12-10.00[0 - 2.5]
grossProfitMarginTTM0.5581.0004.034.03[0.2 - 0.8]
operatingProfitMarginTTM0.2001.0008.018.01[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1591.000-0.226-0.226[0.2 - 2]
assetTurnoverTTM0.6110.8009.267.41[0.5 - 2]
Total Score12.10

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.411.0008.750[1 - 100]
returnOnEquityTTM0.1442.509.6910.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.0002742.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.007022.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.1311.500-4.210[0.5 - 2]
operatingCashFlowSalesRatioTTM0.04271.000-1.4310[0.1 - 0.5]
Total Score3.10

Microbix Biosystems Inc

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.